KYV-101

DB23168InvestigationalCell transplant therapies

KYV-101 is under investigation in clinical trial NCT06152172 (CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101).

Mechanism: Pharmacologically active on B-lymphocyte antigen CD19
Curator reviewed
Code names: KYV-101

Resolves to

Targets

What you can answer from here — as of July 01, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

16Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with KYV-101, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.